Skip to main content
Home
Latest news
Browse topics
Cardiovascular disorders Chronic kidney disease Diabetes devices & technology GLP-1 receptor agonists Hyperglycemia Hypoglycemia Obesity, diet, & lifestyle interventions SGLT2 inhibitors Type 1 diabetes Type 2 diabetes Browse all topics
EN
EN
In focus
Novel clinical evidence in continuous glucose monitoring Fasting for religion and health in people with diabetes The challenge of type 2 diabetes in children HFpEF & diabetes: Diagnosis and management in the wake of EMPEROR-Preserved Addressing suicide risk in diabetes: Rates and risk factors, HCP fears, and practical advice The SURPASS trials: Summarizing efficacy data on tirzepatide Semaglutide for weight loss: STEP and SELECT trials: Results from the STEP and SELECT trials Why psychosocial care matters DiRECT: Type 2 diabetes remission through weight management
Congress coverage
EASD 58th Annual Meeting 2022 The American Diabetes Association 82nd Scientific Sessions
About us
Medicine Matters Diabetes
EXTENDED SEARCH

Type 2 diabetes: Complications

Journal articles and book chapters

08-26-2018 | Cardiovascular disorders | Article

Effects of n−3 fatty acid supplements in diabetes mellitus

The ASCEND Study Collaborative Group. N Eng J Med 2018. doi:  10.1056/NEJMoa1804989

08-22-2018 | Retinopathy | Article

Glucagon-like peptide-1 receptor agonists and the risk of incident diabetic retinopathy

Douros A et al. Diabetes Care 2018: dc172280. doi: 10.2337/dc17-2280

08-22-2018 | Hypoglycemia | Article

Male patients with longstanding type 2 diabetes have a higher incidence of hypoglycemia compared with female patients

Li F et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0492-3

08-18-2018 | Bone health | Review | Article

Lifestyle management of diabetes: implications for the bone-vascular axis

Pieralice S et al. Curr Diab Rep 2018; 18: 84. doi: 10.1007/s11892-018-1060-y

08-17-2018 | Sleep disorders | Review | Article

The epidemiology of sleep and diabetes

Ogilvie RP, Patel SR. Curr Diab Rep 2018; 18: 82. doi: 10.1007/s11892-018-1055-8

08-15-2018 | Pregnancy | Review | Article

Inpatient glycemic management of the pregnant patient

Yeh T, Yeung M, Mendelsohn Curanaj FA. Curr Diab Rep 2018; 18: 73. doi: 10.1007/s11892-018-1045-x

08-13-2018 | Glycemic control | Article

Glycemic control and risk of infections among people with type 1 or type 2 diabetes in a large primary care cohort study

Critchley JA et al. Diabetes Care 2018: dc180287. doi: 10.2337/dc18-0287

08-13-2018 | Glycemic control | Article

The legacy effect in type 2 diabetes: Impact of early glycemic control on future complications (the Diabetes & Aging Study)

Laiteerpong N et al. Diabetes Care 2018: dc171144. doi: 10.2337/dc17-1144

08-06-2018 | Cardiovascular outcomes | Article

Glycemic variation and cardiovascular risk in the Veteran’s Affairs Diabetes Trial

Zhou JJ et al. Diabetes Care 2018: dc180548. doi: 10.2337/dc18-0548

08-02-2018 | Cardiovascular disorders | Article

Progression of cardiovascular autonomic neuropathy and cardiovascular disease in type 2 diabetes

Yun JS et al. Cardiovasc Diabetol 2018; 17: 109. doi: 10.1186/s12933-018-0752-6

08-02-2018 | Sleep apnea | Article

A population-based study of the bidirectional association between obstructive sleep apnea and type 2 diabetes in three prospective US cohorts

Huang T et al. Diabetes Care 2018: dc180675. doi: 10.2337/dc18-0675

08-02-2018 | Diabetic foot | Article

The impact of liraglutide on diabetes-related foot ulceration and associated complications in patients with type 2 diabetes at high risk for cardiovascular events: Results from the LEADER trial

Dhatariya K et al. Diabetes Care 2018: dc181094. doi: 10.2337/dc18-1094

07-25-2018 | Retinopathy | Article

Effects of retinopathy and chronic kidney disease on long-term mortality in type 2 diabetic inpatients with normal urinary albumin or protein: A retrospective cohort study

Li YH, Sheu WH, Lee IT. BMJ Open 2018; 8: e021655. doi: 10.1136/bmjopen-2018-021655

07-23-2018 | SGLT2 inhibitors | Review | Article

SGLT2 inhibitors in type 2 diabetes management: Key evidence and implications for clinical practice

Wilding J et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0471-8

07-18-2018 | Mental health | Review | Article

Cognitive decline and dementia in diabetes mellitus: Mechanisms and clinical implications

Biessels GJ, Despa F. Nat Rev Endocrinol 2018. doi: 10.1038/s41574-018-0048-7

07-10-2018 | Retinopathy | Article

Incidence and progression of diabetic retinopathy: A systematic review

Sabanayagam C et al. Lancet Diabetes Endocrinol 2018. doi: 10.1016/S2213-8587(18)30128-1

07-09-2018 | Neuropathy | Article

Risk-factor trajectories preceding diabetic polyneuropathy: ADDITION-Denmark

Andersen ST et al. Diabetes Care 2018. doi: 10.2337/dc18-0392

07-09-2018 | Retinopathy | Article

Global perspectives on the provision of diabetic retinopathy screening and treatment: Survey of health care professionals in 41 countries

Cavan D et al. Diabetes Res Clin Prac 2018; 143: 170–178. doi: 10.1016/j.diabres.2018.07.004

07-06-2018 | Osteoporosis | Article

FRAX tool in type 2 diabetic subjects: The use of HbA1c in estimating fracture risk

Valentini A et al. Acta Diabetol 2018. doi: 10.1007/s00592-018-1187-y

07-04-2018 | Mental health | Article

Factors associated with type 2 diabetes in patients with vascular dementia: A population-based cross-sectional study

Liu CL et al. BMC Endocr Disord 2018; 18: 45. doi: 10.1186/s12902-018-0273-z

Next Previous
Image Credits